CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 88 enrolled
Drug / intervention
Augmented Standard Medical Care +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00149760
NCT00149760Phase 2Completed
CompareCT.gov

Cognitive Affective Behavior Therapy for Somatization

Rutgers, The State University of New Jersey·interventional·Posted Sep 8, 2005·Updated Feb 20, 2014

In Brief

A Phase 2 clinical trial evaluating Augmented Standard Medical Care and Cognitive-Affective Behavior Therapy for Somatization Disorder. Completed, enrolled 88 participants across 1 site.

Detailed Summary

This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSomatization Disorder
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 8, 2005
Enrollment StartAug 1, 2003
Primary CompletionFeb 1, 2010
TodayJul 2, 2026
Enrollment to primary: 6.5 yearsPosted 20.8 years ago

Interventions

Augmented Standard Medical Carebehavioral

Participants' physicians will receive a letter making specific treatment recommendations for primary care treatment.

Cognitive-Affective Behavior Therapybehavioral

Individually-administered cognitive-behavioral therapy with an emotional focus in addition to augmented standard medical care